{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:02:35Z","timestamp":1784800955685,"version":"3.55.0"},"reference-count":149,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NIH\/NHLBI NIH","doi-asserted-by":"publisher","award":["HL157258"],"award-info":[{"award-number":["HL157258"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"APC","doi-asserted-by":"publisher","award":["AT009991"],"award-info":[{"award-number":["AT009991"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder that affects millions of people globally. Although the mechanisms of COPD pathogenesis are not completely known, oxidative stress and lung inflammation caused by chronic exposure to cigarette smoke, environmental or occupational pollutants, gas from burning biomass fuel are thought to contribute to development of COPD. Therefore, therapies aimed at reducing oxidative stress along with inflammation may be important in treating COPD. However, the current pharmacological therapies treat symptoms and reduce acute exacerbations, but do not treat the root cause of COPD. Quercetin is a plant polyphenol present in berries, apples and onions, and has potent antioxidant and anti-inflammatory properties. Quercetin inhibits oxidative stress by scavenging reactive oxidant species and promoting expression of antioxidant enzymes. It reduces inflammation by inhibiting various kinases that participate in the expression of pro-inflammatory cytokines. It also alters gene expression by functioning as an epigenetic modifier. Quercetin also acts as antiviral agent by attenuating viral entry and replication. In preclinical models of COPD, quercetin reduces oxidative stress, lung inflammation, goblet cell metaplasia, expression of matrix metalloprotease MMP-9 and MMP-12, and prevents rhinovirus-induced progression of emphysema. It also promotes normal regeneration of airway epithelium by improving cell polarization, reducing goblet cell hyperplasia and increasing number of ciliated cells. This review compiles the current understanding of the biological properties of quercetin and its potential therapeutic role in COPD. We also summarize its potential benefits over the current therapeutic drugs used to treat COPD.<\/jats:p>","DOI":"10.3390\/ijms27156548","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:11:26Z","timestamp":1784797886000},"page":"6548","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin in COPD: A Multi-Target Approach to Modulate Inflammation, Oxidative Stress, and Epithelial Dysfunction"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-1469","authenticated-orcid":false,"given":"Priyanka","family":"Sarkar","sequence":"first","affiliation":[{"name":"Center for Inflammation and Lung Research, Lewis-Katz Medical School, Temple University, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umadevi","family":"Sajjan","sequence":"additional","affiliation":[{"name":"Center for Inflammation and Lung Research, Lewis-Katz Medical School, Temple University, Philadelphia, PA 19140, USA"},{"name":"Department of Microbiology, Immunology and Inflammation, Lewis-Katz Medical School, Temple University, Philadelphia, PA 19140, USA"},{"name":"Department of Thoracic Medicine and Surgery, Temple University Health System, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ciupei, D., Coli\u015far, A., Leopold, L., St\u0103nil\u0103, A., and Diaconeasa, Z.M. (2024). Polyphenols: From Classification to Therapeutic Potential and Bioavailability. Foods, 13.","DOI":"10.3390\/foods13244131"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Terao, J. (2023). Potential Role of Quercetin Glycosides as Anti-Atherosclerotic Food-Derived Factors for Human Health. Antioxidants, 12.","DOI":"10.3390\/antiox12020258"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/ham.2013.1014","article-title":"Quercetin reverses hypobaric hypoxia-induced hippocampal neurodegeneration and improves memory function in the rat","volume":"14","author":"Prasad","year":"2013","journal-title":"High Alt. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/15376516.2017.1344338","article-title":"Protective effects of quercetin on nicotine induced oxidative stress in \u2018HepG2 cells\u2019","volume":"27","author":"Yarahmadi","year":"2017","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jat.2812","article-title":"Quercetin reduces oxidative damage induced by paraquat via modulating expression of antioxidant genes in A549 cells","volume":"33","author":"Zerin","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tox.2007.10.006","article-title":"Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats","volume":"243","author":"Muthukumaran","year":"2008","journal-title":"Toxicology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2011.12.005","article-title":"Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38","volume":"195","author":"Martin","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.imbio.2013.04.019","article-title":"Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK\/AP-1 and IKK\/NF-kappaB-induced inflammatory mediators production in RAW 264.7 cells","volume":"218","author":"Endale","year":"2013","journal-title":"Immunobiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100217","DOI":"10.1016\/j.crphar.2025.100217","article-title":"Anti-inflammatory potential of quercetin: From chemistry and mechanistic insight to nanoformulations","volume":"8","author":"Aggarwal","year":"2025","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sul, O.J., and Ra, S.W. (2021). Quercetin Prevents LPS-Induced Oxidative Stress and Inflammation by Modulating NOX2\/ROS\/NF-kB in Lung Epithelial Cells. Molecules, 26.","DOI":"10.3390\/molecules26226949"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/thoraxjnl-2012-201719","article-title":"Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A","volume":"68","author":"Ganesan","year":"2013","journal-title":"Thorax"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e22241","DOI":"10.1097\/MD.0000000000022241","article-title":"Quercetin inhibits TNF-alpha induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3892\/etm.2020.9410","article-title":"Quercetin modulates AMPK\/SIRT1\/NF-kappaB signaling to inhibit inflammatory\/oxidative stress responses in diabetic high fat diet-induced atherosclerosis in the rat carotid artery","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1021624520740","article-title":"Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage","volume":"243","author":"Cho","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"ref_15","first-page":"833","article-title":"Quercetin inhibits a large panel of kinases implicated in cancer cell biology","volume":"38","author":"Boly","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ihj.2018.04.006","article-title":"Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease","volume":"70","author":"Chekalina","year":"2018","journal-title":"Indian. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/jn\/137.5.1208","article-title":"Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells","volume":"137","author":"Ruiz","year":"2007","journal-title":"J. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s44187-024-00265-7","article-title":"Quercetin and rutin as a dual approach to antibacterial and anti-biofilm activity via iron chelation mechanism","volume":"4","author":"Tarabishi","year":"2024","journal-title":"Discov. Food"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100501","DOI":"10.1016\/j.chphi.2024.100501","article-title":"Evaluation of broad-spectrum antibacterial efficacy of quercetin by molecular docking, molecular dynamics simulation and in vitro studies","volume":"8","author":"Majumdar","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/08927014.2025.2460491","article-title":"Antibacterial and antibiofilm efficacy of quercetin against Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus associated with ICU infections","volume":"41","author":"Vijayakumar","year":"2025","journal-title":"Biofouling"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"24415","DOI":"10.1021\/acsomega.2c01819","article-title":"Wound-Healing and Antibacterial Activity of the Quercetin\u20134-Formyl Phenyl Boronic Acid Complex against Bacterial Pathogens of Diabetic Foot Ulcer","volume":"7","author":"Abid","year":"2022","journal-title":"ACS Omega"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.antiviral.2012.03.005","article-title":"Quercetin inhibits rhinovirus replication in vitro and in vivo","volume":"94","author":"Ganesan","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wu, W., Li, R., Li, X., He, J., Jiang, S., Liu, S., and Yang, J. (2015). Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Viruses, 8.","DOI":"10.3390\/v8010006"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Nguyen, T.L.A., and Bhattacharya, D. (2022). Antimicrobial Activity of Quercetin: An Approach to Its Mechanistic Principle. Molecules, 27.","DOI":"10.3390\/molecules27082494"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107435","DOI":"10.1016\/j.intimp.2021.107435","article-title":"Quercetin amelioratesAspergillus fumigatuskeratitis by inhibiting fungal growth, toll-like receptors and inflammatory cytokines","volume":"93","author":"Yin","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/10408398.2023.2278760","article-title":"Epigenetic regulation by quercetin: A comprehensive review focused on its biological mechanisms","volume":"65","author":"Zhu","year":"2025","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18357","DOI":"10.1002\/jcb.29147","article-title":"Quercetin modifies 5\u2032CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells","volume":"120","author":"Hussain","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1021\/acs.jafc.4c10550","article-title":"Role of Quercetin in Modulating Inflammation and Epigenetic Regulation of Staphylococcus aureus-Induced Bovine Mastitis","volume":"73","author":"Shi","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1080\/10408398.2019.1604491","article-title":"The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Tabrizi","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0007114509359127","article-title":"Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study","volume":"102","author":"Egert","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_32","first-page":"627","article-title":"Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial","volume":"19","author":"Rezvan","year":"2018","journal-title":"Cell J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/nutrit\/nuz071","article-title":"Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: A systematic review and meta-analysis","volume":"78","author":"Huang","year":"2020","journal-title":"Nutr. Rev."},{"key":"ref_34","first-page":"100252","article-title":"Effect of oral treatment with quercetin on inflammatory and oxidative stress markers in patients with chronic obstructive pulmonary disease","volume":"7","author":"Patel","year":"2025","journal-title":"Pharmacol. Res.-Nat. Prod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e002489","DOI":"10.1136\/bmjph-2024-002489","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease Study 2021","volume":"4","author":"Cao","year":"2026","journal-title":"BMJ Public Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.2147\/JIR.S478568","article-title":"Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects","volume":"17","author":"Qi","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Barnes, P.J. (2022). Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11050965"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xu, J., Zeng, Q., Li, S., Su, Q., and Fan, H. (2024). Inflammation mechanism and research progress of COPD. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1404615"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15076","DOI":"10.1038\/nrdp.2015.76","article-title":"Chronic obstructive pulmonary disease","volume":"1","author":"Barnes","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/COPD.S34186","article-title":"Exacerbation frequency and course of COPD","volume":"2012","author":"Halpin","year":"2012","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.58.2.100","article-title":"Risk factors of readmission to hospital for a COPD exacerbation: A prospective study","volume":"58","author":"Farrero","year":"2003","journal-title":"Thorax"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/COPD.S4862","article-title":"Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes","volume":"2009","author":"Kesten","year":"2009","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41533-018-0079-5","article-title":"\u2018Exacerbation-free time\u2019 to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): A prospective observational study","volume":"28","author":"Boer","year":"2018","journal-title":"npj Prim. Care Respir. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Seemungal, T.A., Hurst, J.R., and A Wedzicha, J. (2009). Exacerbation rate, health status and mortality in COPD\u2014A review of potential interventions. Int. J. Chronic Obstr. Pulm. Dis., 203.","DOI":"10.2147\/COPD.S3385"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/resp.12099","article-title":"Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission","volume":"18","author":"Wark","year":"2013","journal-title":"Respirology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1378\/chest.129.2.317","article-title":"Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD","volume":"129","author":"Wilkinson","year":"2006","journal-title":"Chest"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/apm.13386","article-title":"Informed development of a multi-species biofilm in chronic obstructive pulmonary disease","volume":"132","author":"Short","year":"2024","journal-title":"APMIS"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Swords, W.E. (2012). Nontypeable Haemophilus influenzae biofilms: Role in chronic airway infections. Front. Cell. Infect. Microbiol., 2.","DOI":"10.3389\/fcimb.2012.00097"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1128\/AEM.02544-14","article-title":"Increased Biofilm Formation by Nontypeable Haemophilus influenzae Isolates from Patients with Invasive Disease or Otitis Media Versus Strains Recovered from Cases of Respiratory Infections","volume":"80","author":"Puig","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2102604","DOI":"10.1183\/13993003.02604-2021","article-title":"Flavonoid intakes inversely associate with COPD in smokers","volume":"60","author":"Bondonno","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sun, M., and Ding, Q. (2024). Correlation of dietary flavonoid intake with chronic bronchitis, emphysema, and asthma in U.S. adults: A large, national, cross-sectional study. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0309310"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lazzara, V., Pinto, P., Di Vincenzo, S., Ferraro, M., Catalano, F., Provinzano, P., Pace, E., and Bonsignore, M.R. (2024). In vitro evidence of antioxidant and anti-inflammatory effects of a new nutraceutical formulation explains benefits in a clinical setting of COPD patients. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1439835"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"V\u00e1squez-Garz\u00f3n, V.R., Vel\u00e1zquez-Enr\u00edquez, J.M., Santos-\u00c1lvarez, J.C., Ram\u00edrez-Hern\u00e1ndez, A.A., Arellanes-Robledo, J., Jim\u00e9nez-Mart\u00ednez, C., and Balti\u00e9rrez-Hoyos, R. (2025). Quercetin in Idiopathic Pulmonary Fibrosis and Its Comorbidities: Gene Regulatory Mechanisms and Therapeutic Implications. Genes, 16.","DOI":"10.3390\/genes16080856"},{"key":"ref_59","first-page":"2621","article-title":"Quercetin Review: Chemistry, Pharmacological Activity, Bioavailability Problems, And Nano Innovations","volume":"4","author":"Gupta","year":"2026","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4014\/jmb.1907.07003","article-title":"A Review on Structure, Modifications and Structure-Activity Relation of Quercetin and Its Derivatives","volume":"30","author":"Magar","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Carrillo-Martinez, E.J., Flores-Hern\u00e1ndez, F.Y., Salazar-Montes, A.M., Nario-Chaidez, H.F., and Hern\u00e1ndez-Ortega, L.D. (2024). Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules, 29.","DOI":"10.20944\/preprints202402.0029.v1"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e33342","DOI":"10.1016\/j.heliyon.2024.e33342","article-title":"Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects\u2014A review","volume":"10","year":"2024","journal-title":"Heliyon"},{"key":"ref_63","first-page":"59","article-title":"An up-to-date review of rutin and its biological and pharmacological activities","volume":"14","author":"Arasu","year":"2015","journal-title":"EXCLI J."},{"key":"ref_64","first-page":"521","article-title":"Flavonoids in foods: A review","volume":"10","author":"Terahara","year":"2015","journal-title":"Nat. Prod. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1021\/jf049571r","article-title":"Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro","volume":"52","author":"Zou","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.3390\/molecules19079453","article-title":"Blumea balsamifera\u2014A phytochemical and pharmacological review","volume":"19","author":"Pang","year":"2014","journal-title":"Molecules"},{"key":"ref_67","first-page":"1024","article-title":"Chemical constituents of leaves of Psidium guajava","volume":"39","author":"Shao","year":"2014","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00614022","article-title":"Disposition of quercetin in man after single oral and intravenous doses","volume":"9","author":"Gugler","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1211\/jpp.61.11.0006","article-title":"Quercetin and naringenin transport across human intestinal Caco-2 cells","volume":"61","author":"Chabane","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1017\/S000711451000053X","article-title":"Oral bioavailability of quercetin from different quercetin glycosides in dogs","volume":"104","author":"Reinboth","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Xiong, H.H., Lin, S.Y., Chen, L.L., Ouyang, K.H., and Wang, W.J. (2023). The Interaction between Flavonoids and Intestinal Microbes: A Review. Foods, 12.","DOI":"10.3390\/foods12020320"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/130.5.1200","article-title":"Bioavailabilities of quercetin-3-glucoside and quercetin-4\u2032-glucoside do not differ in humans","volume":"130","author":"Olthof","year":"2000","journal-title":"J. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/00912700122010366","article-title":"Pharmacokinetics and bioavailability of quercetin glycosides in humans","volume":"41","author":"Graefe","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2010.06.036","article-title":"\u03b1-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans","volume":"501","author":"Murota","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_75","first-page":"S58","article-title":"Quercetin and vitamin C supplementation: Effects on lipid profile and muscle damage in male athletes","volume":"4","author":"Askari","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ejcn.2010.91","article-title":"The variable plasma quercetin response to 12-week quercetin supplementation in humans","volume":"64","author":"Jin","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00394-015-1084-x","article-title":"Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans","volume":"56","author":"Burak","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.foodres.2016.02.013","article-title":"Bioavailability of quercetin in humans and the influence of food matrix comparing quercetin capsules and different apple sources","volume":"88","author":"Petersen","year":"2016","journal-title":"Food Res. Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"46825","DOI":"10.1021\/acsomega.2c05929","article-title":"Enhanced Bioavailability and Pharmacokinetics of a Natural Self-Emulsifying Reversible Hybrid-Hydrogel System of Quercetin: A Randomized Double-Blinded Comparative Crossover Study","volume":"7","author":"Joseph","year":"2022","journal-title":"ACS Omega"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"104663","DOI":"10.1016\/j.jff.2021.104663","article-title":"Bioavailability of dietary isoquercitrin-\u03b3-cyclodextrin molecular inclusion complex in Sprague\u2013Dawley rats and healthy humans","volume":"85","author":"Kapoor","year":"2021","journal-title":"J. Funct. Foods"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13318-018-0517-3","article-title":"Improved Oral Absorption of Quercetin from Quercetin Phytosome\u00ae, a New Delivery System Based on Food Grade Lecithin","volume":"44","author":"Riva","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1021\/mp700077z","article-title":"Intestinal and hepatic glucuronidation of flavonoids","volume":"4","author":"Zhang","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1079\/BJN20061809","article-title":"Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions","volume":"96","author":"Mullen","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9727539","DOI":"10.1155\/2023\/9727539","article-title":"A Pharmacokinetic Study of Different Quercetin Formulations in Healthy Participants: A Diet-Controlled, Crossover, Single- and Multiple-Dose Pilot Study","volume":"2023","author":"Solnier","year":"2023","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.605","article-title":"Quercetin pharmacokinetics in humans","volume":"29","author":"Moon","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1111\/j.1750-3841.2012.02934.x","article-title":"Comparison of quercetin pharmacokinetics following oral supplementation in humans","volume":"77","author":"Kaushik","year":"2012","journal-title":"J. Food Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/jpet.302.2.804","article-title":"Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele frequencies in the Japanese population and functional analysis","volume":"302","author":"Nozawa","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(97)01367-7","article-title":"Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man","volume":"418","author":"Hollman","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jn\/138.9.1615","article-title":"Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans","volume":"138","author":"Egert","year":"2008","journal-title":"J. Nutr."},{"key":"ref_90","first-page":"1134","article-title":"Antioxidant Activity of Quercetin: A Mechanistic Review","volume":"4","author":"Ozgen","year":"2016","journal-title":"Turk. J. Agric.\u2014Food Sci. Technol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.22159\/ajpcr.2017.v10i11.20260","article-title":"Investigation of antioxidant potential of quercetin and hesperidin: An in vitro approach","volume":"10","author":"Vijayalakshmi","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00894-020-04356-x","article-title":"Mechanism of antioxidant properties of quercetin and quercetin-DNA complex","volume":"26","author":"Song","year":"2020","journal-title":"J. Mol. Model."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: From antioxidant to nutraceutical","volume":"585","author":"Boots","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100930","DOI":"10.1016\/j.jpha.2023.12.020","article-title":"New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation","volume":"14","author":"Zhang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Jin, H., Zhang, L., He, J., Wu, M., Jia, L., and Guo, J. (2022). Role of FOXO3a Transcription Factor in the Regulation of Liver Oxidative Injury. Antioxidants, 11.","DOI":"10.3390\/antiox11122478"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"23074","DOI":"10.1038\/s41598-024-73075-7","article-title":"Quercetin as a therapeutic agent activate the Nrf2\/Keap1 pathway to alleviate lung ischemia-reperfusion injury","volume":"14","author":"Keshavarz","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Boo, H.J., Yoon, D., Choi, Y., Kim, Y., Cha, J.S., and Yoo, J. (2025). Quercetin: Molecular Insights into Its Biological Roles. Biomolecules, 15.","DOI":"10.3390\/biom15030313"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jep.2013.12.033","article-title":"Myrsine seguinii ethanolic extract and its active component quercetin inhibit macrophage activation and peritonitis induced by LPS by targeting to Syk\/Src\/IRAK-1","volume":"151","author":"Yang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid","volume":"10","author":"David","year":"2016","journal-title":"Pharmacogn. Rev."},{"key":"ref_100","first-page":"182","article-title":"Quercetin inhibits the activity and function of dendritic cells through the TLR4\/IRAK4\/NF-\u03baB signaling pathway","volume":"27","author":"Kang","year":"2023","journal-title":"Contemp. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"41539","DOI":"10.1038\/srep41539","article-title":"Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis","volume":"7","author":"Domiciano","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/jn\/135.10.2299","article-title":"Quercetin Decreases Oxidative Stress, NF-\u03baB Activation, and iNOS Overexpression in Liver of Streptozotocin-Induced Diabetic Rats","volume":"135","author":"Dias","year":"2005","journal-title":"J. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2101505","DOI":"10.1002\/smll.202101505","article-title":"Quercetin-Loaded Ceria Nanocomposite Potentiate Dual-Directional Immunoregulation via Macrophage Polarization against Periodontal Inflammation","volume":"17","author":"Wang","year":"2021","journal-title":"Small"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ptr.7309","article-title":"Quercetin and its derivates as antiviral potentials: A comprehensive review","volume":"36","author":"Fais","year":"2022","journal-title":"Phytother. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bmcl.2011.10.119","article-title":"Synthesis and antiviral activity of substituted quercetins","volume":"22","author":"Thapa","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"480764","DOI":"10.1155\/2015\/480764","article-title":"Molecular Docking of Potential Inhibitors for Influenza H7N9","volume":"2015","author":"Liu","year":"2015","journal-title":"Comput. Math. Methods Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/138955751410141020150822","article-title":"Viral M2 ion channel protein: A promising target for anti-influenza drug discovery","volume":"14","author":"Moorthy","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.phymed.2016.06.001","article-title":"Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence","volume":"23","author":"Gansukh","year":"2016","journal-title":"Phytomedicine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ptr.3529","article-title":"Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice","volume":"26","author":"Choi","year":"2012","journal-title":"Phytother. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2010.08.016","article-title":"Inhibition of influenza virus replication by plant-derived isoquercetin","volume":"88","author":"Kim","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/019021490927088","article-title":"Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection","volume":"31","author":"Kumar","year":"2005","journal-title":"Exp. Lung Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3892\/br.2013.141","article-title":"Effects of quercetin on CDK4 mRNA and protein expression in A549 cells infected by H1N1","volume":"1","author":"Wan","year":"2013","journal-title":"Biomed. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2015.01.018","article-title":"Role of dietary antioxidants in human metapneumovirus infection","volume":"200","author":"Komaravelli","year":"2015","journal-title":"Virus Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"197805","DOI":"10.1016\/j.virusres.2019.197805","article-title":"Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion","volume":"276","author":"Lopes","year":"2020","journal-title":"Virus Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijbiomac.2017.12.141","article-title":"Binding investigation between M2-1protein from hRSV and acetylated quercetin derivatives: 1H NMR, fluorescence spectroscopy, and molecular docking","volume":"111","author":"Piva","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13205-020-02578-7","article-title":"In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2","volume":"11","author":"Hiremath","year":"2021","journal-title":"3 Biotech"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Manjunathan, R., Periyaswami, V., Mitra, K., Rosita, A.S., Pandya, M., Selvaraj, J., Ravi, L., Devarajan, N., and Doble, M. (2022). Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein. BMC Bioinform., 23.","DOI":"10.1186\/s12859-022-04724-9"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.csbj.2020.11.010","article-title":"Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor","volume":"18","author":"Pan","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1021\/acs.jcim.0c01010","article-title":"Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to COVID-19","volume":"60","author":"Acharya","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12985-024-02299-w","article-title":"Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2","volume":"21","author":"Roy","year":"2024","journal-title":"Virol. J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/IJGM.S318949","article-title":"Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial","volume":"14","author":"Iqtadar","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Di Pierro, F., Khan, A., Iqtadar, S., Mumtaz, S.U., Chaudhry, M.N.A., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., and Riva, A. (2022). Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1096853"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"11334","DOI":"10.1128\/JVI.78.20.11334-11339.2004","article-title":"Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells","volume":"78","author":"Yi","year":"2004","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"155761","DOI":"10.1016\/j.phymed.2024.155761","article-title":"Quercetin induces itaconic acid-mediated M1\/M2 alveolar macrophages polarization in respiratory syncytial virus infection","volume":"130","author":"An","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/s41598-023-35272-8","article-title":"Integrating metabolomics and network pharmacology to assess the effects of quercetin on lung inflammatory injury induced by human respiratory syncytial virus","volume":"13","author":"Sun","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114510","DOI":"10.1016\/j.intimp.2025.114510","article-title":"Exploring quercetin based nano formulation in combating human Metapneumovirus infections","volume":"153","author":"Bhuvaneshwari","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e001740","DOI":"10.1136\/bmjresp-2023-001740","article-title":"Risk factors of acute exacerbation and disease progression in young patients with COPD","volume":"11","author":"Bae","year":"2024","journal-title":"BMJ Open Resp. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1465-9921-11-131","article-title":"Quercetin prevents progression of disease in elastase\/LPS-exposed mice by negatively regulating MMP expression","volume":"11","author":"Ganesan","year":"2010","journal-title":"Respir. Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Farazuddin, M., Mishra, R., Jing, Y., Srivastava, V., Comstock, A.T., and Sajjan, U.S. (2018). Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199612"},{"key":"ref_130","first-page":"205","article-title":"Quercetin Attenuates Acute Lung Injury Caused by Cigarette Smoke Both In Vitro and In Vivo","volume":"17","year":"2020","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"156491","DOI":"10.1016\/j.phymed.2025.156491","article-title":"Quercetin improves airway remodeling in COPD rats by suppressing phenotypic switch of ASMCs via inhibiting the Wnt5a\/\u03b2-catenin pathway","volume":"139","author":"Zhou","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Yin, C., Tian, Y., Yan, A., Wang, H., Lu, F., Li, X., Li, X., Han, S., Miao, R., and Chen, H. (2024). Mitigating inflammation and fibrosis: The therapeutic potential of quercetin liposomes in COPD. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1503283"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1465-9921-15-11","article-title":"Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice","volume":"15","author":"Ganesan","year":"2014","journal-title":"Respir. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200911-1673OC","article-title":"Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease","volume":"182","author":"Schneider","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12931-024-02742-0","article-title":"Quercetin improves epithelial regeneration from airway basal cells of COPD patients","volume":"25","author":"McCluskey","year":"2024","journal-title":"Respir. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/thoraxjnl-2017-210593","article-title":"NOTCH3 contributes to rhinovirus-induced goblet cell hyperplasia in COPD airway epithelial cells","volume":"74","author":"Jing","year":"2019","journal-title":"Thorax"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ajcn\/76.3.560","article-title":"Flavonoid intake and risk of chronic diseases","volume":"76","author":"Knekt","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1164\/ajrccm.164.1.2010025","article-title":"Chronic Obstructive Pulmonary Disease and Intake of Catechins, Flavonols, and Flavones","volume":"164","author":"Tabak","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e000392","DOI":"10.1136\/bmjresp-2018-000392","article-title":"Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease","volume":"7","author":"Han","year":"2020","journal-title":"BMJ Open Resp. Res."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Miravitlles, M., Kawayama, T., and Dreher, M. (2022). LABA\/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. J. Clin. Med., 11.","DOI":"10.3390\/jcm11226623"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","article-title":"Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Nici","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: A review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(12)60304-3","article-title":"Side-effects of roflumilast","volume":"379","author":"Gupta","year":"2012","journal-title":"Lancet"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2147\/COPD.S307160","article-title":"A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy","volume":"16","author":"Ferguson","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.chest.2024.08.034","article-title":"Ensifentrine for COPD: Identifying the Patients Who Benefit","volume":"167","author":"Suri","year":"2025","journal-title":"Chest"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jfda.2018.12.006","article-title":"Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease","volume":"27","author":"Wang","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"ref_148","first-page":"PA2472","article-title":"The safety of LAMA\/LABA combination therapy for the ocular and urinary adverse effects in the COPD patients","volume":"54","author":"Ohtsuka","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41573-025-01290-6","article-title":"Treatment of chronic obstructive pulmonary disease: Current pipeline and new opportunities","volume":"25","author":"Agusti","year":"2026","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6548\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:15:36Z","timestamp":1784798136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":149,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156548"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156548","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}